Tata Chemicals Expects Margins To Improve In Q3-Q4 Led By Volume Growth
Tata Chemicals expects some margin fluctuations through FY26, with a softer Q2 due to the monsoon season impacting construction work and detergent demand in India and Southeast Asia, the company's MD and CEO, R Mukundan, said on Monday.
Speaking to NDTV Profit, Mukundan said that margins are expected to rebound in Q3 and Q4 as volumes recover.
“Let me just say that Q2 tends to be a softer quarter for us compared to Q1. This is mainly because during the monsoon season, construction activity slows down and demand in the detergent sector also dips. Barring that, I think Q3 and Q4 will see an uptick and return to normal levels. By the end of Q3, we also expect additional storage capacity to become operational at Mitapur (Gujarat),” he said.
The company also expects its UK pharma plant, commissioned in Q1, to start contributing in Q2. Additionally, by December-end, Tata Chemicals expects some debottlenecking to be completed in India, which should boost volumes, according to Mukundan.
“So, yes, there will be a volume impact, and cost efficiencies will continue to play out. In terms of market volume or dispatches, we anticipate a moving number, with a slight dip due to the monsoon, followed by a pickup in Q3 and Q4,” he noted.
In Q1FY26, the speciality chemicals arm of the Tata Group reported lower volumes and revenue, largely due to the planned closure of a UK unit as part of a broader restructuring strategy. With this, Mukundan explained that the company expects to realise Rs 600 crore in benefits this year.
“There will be something like a one-third, one-third, one-third benefit coming this year….Rs 200 crore coming from the cessation of operations in the UK, Rs 200 crore from the new capacity additions in India, and another Rs 200 crore coming in from cost-out….I think all three are playing out….As we speak, the only lever we need to work on is the working capital lever, which we need to sort of rationalise,” he explained.
The company has targeted to reduce debt by Rs 500 to Rs 600 crore this fiscal, with an overall target of Rs 1,500 crore over the next two years. On the global outlook, Mukundan said that growth is seen mainly in India, South America, and Southeast Asia, while places like China are seeing a slowdown.
“In terms of the market outlook, we have actually planned for the market to be more or less flat. The growth engines continue to be India and parts of America, especially the South American market and Southeast Asian market, which continue to grow. We do believe that in China, there is a bit of a slowdown happening .....we would fundamentally see our volumes fully sold out and we have not planned for any increase in prices,” he said.
Tata Chemicals Q1 Results
In Q1FY26, Tata Chemicals reported consolidated revenue of Rs 3,719 crore, slightly down from Rs 3,789 crore in Q1FY25. However, the company's Ebitda improved 13% to Rs 649 crore from Rs 574 crore in the same period last year. It reported an increase in margins to 17% compared to 15% in the year-ago quarter. Profit after tax (PAT) reached Rs 316 crore against Rs 175 crore in Q1FY25, marking an 80% YoY jump.
Tata Chemicals shares were trading 0.56% lower at Rs 936.1 apiece on the NSE at 3:11 p.m. In comparison, the benchmark Nifty50 stood at 24,685.35, down 0.61% in the closing session.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.